Chemsex and Mental Health of Men Who Have Sex With Men in Germany

Annette Bohn, Dirk Sander, Thorsten Köhler, Nico Hees, Felix Oswald, Norbert Scherbaum, Daniel Deimel, Henrike Schecke, Annette Bohn, Dirk Sander, Thorsten Köhler, Nico Hees, Felix Oswald, Norbert Scherbaum, Daniel Deimel, Henrike Schecke

Abstract

Background: Chemsex is defined as using certain substances immediately before or during sexual activities to facilitate, prolong and/or intensify sexual experience, mainly by some communities of men who have sex with men (MSM). Four substances are typically associated with chemsex: methamphetamine, mephedrone, GHB/GBL, and ketamine. While there is a lot of evidence for increased prevalence of HIV, sexually transmitted infections and other sexual health measures among MSM, who engage in chemsex, there has been little research on mental health aspects. This study aims to describe aspects of mental health among a sample of German men who have sex with men (MSM) who engage in chemsex and to describe potentially adverse consequences of chemsex behavior. Method: This paper refers to a subset of participants from the German Chemsex Survey, an MSM-community recruited, self-completed online survey with a self-selected convenience sample. The survey comprised 420 different items considering recreational substance use, substance use in sexual settings, mental health, sexual transmitted infections, adverse consequences of chemsex behavior, and experiences of non-consensual sex acts. A group of participants who used methamphetamine, mephedrone, GHB/GBL, and/or ketamine in a sexual setting in the last 12 months (n = 280, chemsex group) was analyzed regarding symptoms of depression (PHQ-9), general anxiety disorder (GAD-7), somatization (PHQ-15), and PTSD (Primary Care PTSD Screen). Group comparisons were conducted between the chemsex group and men who did not use substances in a sexual context (n = 177, non-chemsex group). Mean scores of mental health measures were compared, as well as scores above a cut-off that indicates clinically relevant symptoms. Logistical regression was utilized to determine whether mental health measures can predict adverse consequences of engagement in chemsex behaviors. Results: A total of 1,583 men started the survey; 1,050 participants provided information on substance use. Twenty-seven percent of participants (n = 280) reported that they used methamphetamine, mephedrone, GHB/GBL and/or ketamine in a sexual setting in the last 12 months. The chemsex group showed significantly higher mean scores for depression, anxiety, and somatization than the non-chemsex group, but effect sizes were low. Even though mean scores were heightened, they were still far below the cut-off for clinically relevant symptoms. The chemsex group reported significantly higher incidences of non-consensual sex acts compared with the non-chemsex group. Some men in the chemsex-group experienced potentially adverse consequences, such as loss of control regarding time and money spent for chemsex activities or amount of substances used at one occasion (49.6%), negative impacts on social functioning (33.6%), psychotic symptoms (13.2%), and physically aggressive behavior toward others (2.9%). Clinically relevant symptoms did not predict a higher likelihood for adverse consequences. Discussion: Mean scores for depression, anxiety, and somatization were significantly higher in the chemsex-group, but effect sizes were low. Both groups reported poorer mental health compared to men in the German general population. Mental health measures did not contribute to predict potentially adverse consequences of chemsex behavior.

Keywords: HIV; chemsex; men who have sex with men; mental health; party and play (PNP); sexualised drug use.

Copyright © 2020 Bohn, Sander, Köhler, Hees, Oswald, Scherbaum, Deimel and Schecke.

Figures

Figure 1
Figure 1
Development of participants' numbers in the course of the survey.

References

    1. Bourne A, Reid D, Hickson F, Torres Rueda S, Weatherburn P. The Chemsex Study: Drug Use in Sexual Settings Among Gay and Bisexual Men in Lambeth, Southwark and Lewisham. Technical Report. London: Sigma Research, London School of Hygiene & Tropical Medicine; (2014).
    1. Bourne A, Reid D, Hickson F, Torres-Rueda S, Steinberg P, Weatherburn P. “Chemsex” and harm reduction need among gay men in South London. Int J Drug Policy. (2015) 26:1171–6. 10.1016/j.drugpo.2015.07.013
    1. Edmundson C, Heinsbroek E, Glass R, Hope V, Mohammed H, White M, et al. . Sexualised drug use in the United Kingdom (UK): A review of the literature. Int J Drug Policy. (2018) 55:131–48. 10.1016/j.drugpo.2018.02.002
    1. Frankis J, Flowers P, McDaid L, Bourne A. Low levels of chemsex among men who have sex with men, but high levels of risk among men who engage in chemsex: analysis of a cross-sectional online survey across four countries. Sexual Health. (2018) 15:144–50. 10.1071/SH17159
    1. Pakianathan M, Whittaker W, Lee MJ, Avery J, Green S, Nathan B, et al. . Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. (2018) 19:485–90. 10.1111/hiv.12629
    1. Rosińska M, Gios L, Nöstlinger C, Vanden Berghe W, Marcus U, Schink S, et al. . Prevalence of drug use during sex amongst MSM in Europe: Results from a multi-site bio-behavioural survey. Int J Drug Policy. (2018) 55:231–41. 10.1016/j.drugpo.2018.01.002
    1. Pufall EL, Kall M, Shahmanesh M, Nardone A, Gilson R, Delpech V, et al. . Sexualized drug use (‘chemsex’) and high-risk sexual behaviours in HIV-positive men who have sex with men. HIV Med. (2018) 19:261–70. 10.1111/hiv.12574
    1. Glynn RW, Byrne N, O'Dea S, Shanley A, Codd M, Keenan E, et al. . Chemsex, risk behaviours and sexually transmitted infections among men who have sex with men in Dublin, Ireland. Int J Drug Policy. (2018) 52:9–15. 10.1016/j.drugpo.2017.10.008
    1. Sewell J, Miltz A, Lampe FC, Cambiano V, Speakman A, Phillips AN, et al. . Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. Int J Drug Policy. (2017) 43:33–43. 10.1016/j.drugpo.2017.01.001
    1. Hibbert MP, Brett CE, Porcellato LA, Hope VD. Psychosocial and sexual characteristics associated with sexualised drug use and chemsex among men who have sex with men (MSM) in the UK. Sex Transm Infect. (2019) 95:342–50. 10.1136/sextrans-2018-053933
    1. Melendez-Torres GJ, Hickson F, Reid D, Weatherburn P, Bonell C. Findings from within-subjects comparisons of drug use and sexual risk behaviour in men who have sex with men in England. Int J STD AIDS. (2017) 28:250–8. 10.1177/0956462416642125
    1. King M, Semlyen J, Tai SS, Killaspy H, Osborn D, Popelyuk D, et al. . A systematic review of mental disorder, suicide, and deliberate self harm in lesbian, gay and bisexual people. BMC Psychiatry. (2008) 8:70. 10.1186/1471-244X-8-70
    1. Meyer IH. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. Psychol Bull. (2003) 129:674–97. 10.1037/0033-2909.129.5.674
    1. Miltz AR, Rodger AJ, Sewell J, Speakman A, Phillips AN, Sherr L, et al. . Clinically significant depressive symptoms and sexual behaviour among men who have sex with men. BJPsych open. (2017) 3:127–37. 10.1192/bjpo.bp.116.003574
    1. Alvy LM, McKirnan DJ, Mansergh G, Koblin B, Colfax GN, Flores SA, et al. . Depression is associated with sexual risk among men who have sex with men, but is mediated by cognitive escape and self-efficacy. AIDS Behav. (2011) 15:1171–9. 10.1007/s10461-010-9678-z
    1. Durso LE, Meyer IH. Patterns and predictors of disclosure of sexual orientation to healthcare providers among lesbians, gay men, and bisexuals. Sex Res Soc Policy. (2013) 10:35–42. 10.1007/s13178-012-0105-2
    1. Kertzner RM, Meyer IH, Frost DM, Stirratt MJ. Social and psychological weil-being in lesbians, gay men, and bisexuals: the effects of race, gender, age, and sexual identity. Am J Orthopsychiatry. (2009) 79:500–10. 10.1037/a0016848
    1. Lea T, Hammoud M, Bourne A, Maher L, Jin F, Haire B, et al. . Attitudes and perceived social norms toward drug use among gay and bisexual men in Australia. Subst Use Misuse. (2019). 54:944–54. 10.1080/10826084.2018.1552302
    1. Pollard A, Nadarzynski T, Llewellyn C. Syndemics of stigma, minority-stress, maladaptive coping, risk environments and littoral spaces among men who have sex with men using chemsex. Cult Health Sexual. (2018) 20:411–27. 10.1080/13691058.2017.1350751
    1. Smith V, Tasker F. Gay men's chemsex survival stories. Sex Health. (2018) 15:116–22. 10.1071/SH17122
    1. Prestage G, Hammoud M, Jin F, Degenhardt L, Bourne A, Maher L. Mental health, drug use and sexual risk behavior among gay and bisexual men. Int J Drug Policy. (2018) 55:169–79. 10.1016/j.drugpo.2018.01.020
    1. Bui H, Zablotska-Manos I, Hammoud M, Jin F, Lea T, Bourne A, et al. . Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: results from the FLUX study. Int J Drug Policy. (2018) 55:222–30. 10.1016/j.drugpo.2018.01.018
    1. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. (2001) 158:725–30. 10.1176/appi.ajp.158.5.725
    1. Nanni MG, Caruso R, Mitchell AJ, Meggiolaro E, Grassi L. Depression in HIV infected patients: a review. Curr Psychiatry Rep. (2015) 17:530. 10.1007/s11920-014-0530-4
    1. Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. (2017) 389:941–50. 10.1016/S0140-6736(17)30003-X
    1. Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. (2003) 17:423–41. 10.1525/maq.2003.17.4.423
    1. Gräfe K, Zipfel S, Herzog W, Löwe B. Screening psychischer Störungen mit dem “Gesundheitsfragebogen für Patienten (PHQ-D).” Diagnostica. (2004) 50:171–81. 10.1026/0012-1924.50.4.171
    1. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. (2001) 16:606–13. 10.1046/j.1525-1497.2001.016009606.x
    1. Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. (2006) 166:1092–7. 10.1001/archinte.166.10.1092
    1. Kocalevent RD, Hinz A, Brähler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. (2013) 13:91. 10.1186/1471-244X-13-91
    1. Cameron RP, Gusman D. The primary care PTSD screen (PC-PTSD): development and operating characteristics. Primary Care Psychiatry. (2003) 9:9–14. 10.1185/135525703125002360
    1. Schäfer I, Schulze C. Deutsche Version des “Primary CarePosttraumatic Stress Disorder screening questionnaire.” Universität Hamburg (2010).
    1. Ehring T, Knaevelsrud C, Krüger A, Schäfer I. Life Events Checklist für DSM-5 (LEC-5): Deutsche Version. German version. Events Checklist for DSM-5 (Hamburg: LEC-5; ) (2014).
    1. Weathers F, Blake D, Schnurr P, Kaloupek D, Marx B, Keane T. The Life Events Checklist for DSM-5 (LEC-5). (2013) Available online at: (accessed June 15, 2020).
    1. Glaesmer H, Kapusta ND, Teismann T, Wagner B, Hallensleben N, Spangenberg L, et al. . Psychometrische eigenschaften der deutschen version des suicide behaviors questionnaire revised (SBQ-R). Psychother Psycho Med Psychol. (2018) 68:346–52. 10.1055/s-0043-118335
    1. Osman A, Bagge CL, Gutierrez PM, Konick LC, Kopper BA, Barrios FX. The suicidal behaviors questionnaire-revised (SBQ-R): validation with clinical and nonclinical samples. Assessment. (2001) 8:443–54. 10.1177/107319110100800409
    1. Deimel D, Stöver H, Hößelbarth S, Dichtl A, Graf N, Gebhardt V. Drug use and health behaviour among German men who have sex with men: results of a qualitative, multi-centre study. Harm Reduc J. (2016) 13:36. 10.1186/s12954-016-0125-y
    1. Busch M, Maske U, Ryl L, Schlack R, Hapke U. Prevalence of depressive symptoms and diagnosed depression among adults in Germany: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. (2013) 56:733–9. 10.1007/s00103-013-1688-3
    1. Hinz A, Klein AM, Brähler E, Glaesmer H, Luck T, Riedel-Heller SG, et al. . Psychometric evaluation of the generalized anxiety disorder screener GAD-7, based on a large German general population sample. J Affect Disord. (2017) 210:338–44. 10.1016/j.jad.2016.12.012
    1. Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, et al. . Mental disorders in the general population. Study on the health of adults in Germany and the additional module mental health (DEGS1-MH). Nervenarzt. (2014) 85:77–87. 10.1007/s00115-013-3961-y
    1. Björkenstam C, Kosidou K, Björkenstam E, Dalman C, Andersson G, Cochran S. Self-reported suicide ideation and attempts, and medical care for intentional self-harm in lesbians, gays and bisexuals in Sweden. J Epidemiol Community Health. (2016) 70:895–901. 10.1136/jech-2015-206884
    1. Graf N, Dichtl A, Deimel D, Sander D, Stöver H. Chemsex among men who have sex with men in Germany: motives, consequences and the response of the support system. Sexual Health. (2018) 15:151–6. 10.1071/SH17142
    1. Duncan DT, Goedel WC, Stults CB, Brady WJ, Brooks FA, Blakely JS, et al. . A study of intimate partner violence, substance abuse, and sexual risk behaviors among gay, bisexual, and other men who have sex with men in a sample of geosocial-networking smartphone application users. Am J Mens Health. (2018) 12:292–301. 10.1177/1557988316631964
    1. Buller AM, Devries KM, Howard LM, Bacchus LJ. Associations between intimate partner violence and health among men who have sex with men: a systematic review and meta-analysis. PLoS Med. (2014) 11:e1001609. 10.1371/journal.pmed.1001609
    1. Stall R, Mills TC, Williamson J, Hart T, Greenwood G, Paul J, et al. . Association of co-occurring psychosocial health problems and increased vulnerability to HIV/AIDS among urban men who have sex with men. Am J Public Health. (2003) 93:939–42. 10.2105/AJPH.93.6.939
    1. Mercer CH, Prah P, Field N, Tanton C, Macdowall W, Clifton S, et al. . The health and well-being of men who have sex with men (MSM) in Britain: evidence from the third national survey of sexual attitudes and lifestyles (Natsal-3). BMC Public Health. (2016) 16:525. 10.1186/s12889-016-3149-z
    1. EMIS Network EMIS 2010: The European Men-Who-Have-Sex-with-Men Internet Survey . FINDINGS from 38 Countries. European Centre for Disease Prevention and Control (2013). Retrieved from (accessed July 19, 2020).
    1. Bremer V, Dudareva-Vizule S, Buder S, der Heiden M, Jansen K. Sexuell übertragbare Infektionen in Deutschland. Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz. (2017) 60:948–57. 10.1007/s00103-017-2590-1
    1. Poethko-Müller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, et al. . Epidemiology of hepatitis A, B, and C among adults in Germany: Results of the German health interview and examination survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. (2013) 56:707–15. 10.1007/s00103-013-1673-x
    1. Burgess K, Parkhill G, Wiggins J, Ruth S, Stoovè M. Re-wired: treatment and peer support for men who have sex with men who use methamphetamine. Sexual Health. (2018) 15:157–9. 10.1071/SH17148
    1. Schecke H, Lea T, Bohn A, Kohler T, Sander D, Scherbaum N, et al. . Crystal methamphetamine use in sexual settings among German men who have sex with men. Front Psychiatry. (2019) 10:886. 10.3389/fpsyt.2019.00886
    1. Bakker I, Knoops L. Towards a continuum of care concerning chemsex issues. Sexual Health. (2018) 15:173–5. 10.1071/SH17139

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir